Skip to main content

Table 3 Characteristics of the 1,914 Greek patients stratified according to four degrees of severity by APACHE II score and serum suPAR

From: Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor

 

APACHE II score <17 + suPAR <12 ng/mL

APACHE II score <17 + suPAR ≥12 ng/mL

APACHE II score ≥17 + suPAR <12 ng/mL

APACHE II score ≥17 + suPAR ≥12 ng/mL

P value

Male/female

480/413

162/172

170/123

216/178

0.014

Age in years, mean ± SD

59.4 ± 21.4

68.3 ± 18.7

73.3 ± 14.9

74.2 ± 13.7

<0.0001

Sepsis stage, number (percentage)

    

<0.0001

   Sepsis

747 (83.6)

232 (67.4)

113 (38.6)

95 (24.1)

 

   Severe sepsis

105 (11.8)

68 (20.3)

105 (35.8)

134 (34.0)

 

   Septic shock

41 (4.6)

43 (12.9)

75 (25.6)

164 (41.6)

 

Underlying infections, number (percentage)

    

<0.0001

   CAP

169 (18.9)

55 (16.5)

93 (31.7)

87 (22.1)

 

   HAP

32 (3.6)

12 (3.6)

30 (10.2)

35 (8.9)

 

   VAP

29 (2.3)

15 (4.5)

30 (10.2)

48 (12.2)

 

   UTI

346 (38.7)

128 (38.3)

67 (22.9)

94 (23.9)

 

   IAI

260 (29.1)

80 (23.9)

35 (11.9)

61 (15.5)

 

   BSI

57 (6.4)

44 (13.2)

38 (12.9)

69 (17.5)

 

Underlying conditions, number (percentage)

    

<0.0001

   COPD

78 (8.7)

33 (9.9)

45 (15.4)

54 (13.7)

 

   DM2

143 (16.1)

90 (26.9)

74 (25.3)

123 (31.2)

 

   Heart failure

104 (11.6)

49 (14.7)

62 (21.2)

98 (24.8)

 

   CRD

35 (3.9)

29 (8.7)

27 (9.2)

85 (21.6)

 

   Intake of corticosteroids

27 (3.0)

8 (2.3)

16 (5.5)

22 (5.6)

 

   Malignancy

42 (4.7)

18 (5.4)

17 (5.8)

30 (7.6)

 

Length of ICU staya in days, median (range)

19.5 (1-312)

20.0 (2-317)

22.5 (1-309)

14.5 (1-240)

0.196

  1. aRefers only to patients hospitalized in an intensive care unit (ICU). APACHE II, Acute Physiology and Chronic Health Evaluation II; BSI, bloodstream infection; CAP, community-acquired pneumonia; COPD, chronic obstructive pulmonary disorder; CRD, chronic renal disease; DM2, diabetes mellitus type 2; HAP, hospital-acquired pneumonia; IAI, intrabdominal infection; SD, standard deviation; suPAR, soluble urokinase plasminogen activator receptor; UTI, urinary tract infection; VAP, ventilator-associated pneumonia.